サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1126254

ヘリコバクターピロリ非侵襲的検査市場の2028年までの予測-検査タイプ、検査方法、エンドユーザー別の世界分析

Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type, Test Method, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 177 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヘリコバクターピロリ非侵襲的検査市場の2028年までの予測-検査タイプ、検査方法、エンドユーザー別の世界分析
出版日: 2022年08月18日
発行: The Insight Partners
ページ情報: 英文 177 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘリコバクターピロリ（H. pylori）非侵襲的検査市場は、2021年の5億9682万米ドルから2028年には8億4万米ドルに成長すると予測され、2022年から2028年までのCAGRは4.4%と推定されています。

ピロリ菌感染の有病率の増加、ピロリ菌の診断に関する個人の意識の広がり、新製品の発売とFDAの承認が、市場全体の成長を後押ししています。

老化はピロリ菌感染のリスクを高めるため、胃疾患の有病率は老年人口において著しく高くなります。年齢の増加は、このように細菌が高齢者の間で感染の有病率の増加に寄与する保護膜を通過することができ、胃粘膜の菲薄化につながります。世界保健機関（WHO）によると、2030年には60歳以上の人口比率が世界で13.7％、東南アジア地域で20.3％になると予想されています。それに伴う老年人口の増加に伴い、臨床的・機能的合併症のスクリーニング、評価、管理などのプライマリーケアサービスに対する需要が高まっています。これらの統計は、世界中のさまざまな地域における診断の必要性の増加を決定づけ、予測期間中のヘリコバクターピロリ（H. pylori）非侵襲的検査市場の成長を後押ししています。

ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場の概要セグメント別概要

検査タイプに基づき、ヘリコバクターピロリ（H. pylori）非侵襲的検査市場は、血清検査、便中抗原、および尿素呼気に区分されます。尿素呼気セグメントは2021年に最大の市場シェアを占め、著名なプレーヤー間の製品開発動向の上昇により、予測期間中に最高のCAGRを記録すると予想されます。検査方法に基づき、ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場は、ラボベースとポイントオブケアに二分化されます。2021年には、ラボベースセグメントがより大きな市場シェアを占め、医療従事者が検査手順を操作し、診断手順をより正確にするため、2022年から2028年にかけて高いCAGRを記録すると予測されます。エンドユーザーに基づいて、ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場は、病院、診療所、診断ラボに区分されます。2021年には、診断ラボラトリー部門が市場で最大のシェアを占め、ラボで実施される検査数の増加や業界における競争の激化により、競争力のある価格と最良のサービスが求められるため、2022年から2028年にかけて最高のCAGRを記録すると予想されています。

ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場。地域別概要

ヘリコバクターピロリ（H. pylori）非侵襲的検査の世界市場では、北米が最大のシェアを占めており、アジア太平洋地域は最も急速に成長している地域となっています。北米の市場は、胃がん、十二指腸潰瘍、胃潰瘍の有病率の上昇と医療施設の発展により、予測期間中に成長すると予想されます。

アジア太平洋地域は、予測期間中に世界のH.ピロリ非侵襲的検査市場で最も高いCAGRを記録すると思われます。同地域の市場は、今後、中国、インド、日本を含むさまざまな国で大きく成長することが予想されます。アジア太平洋地域のヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場は、高齢者人口の増加、ピロリの高い有病率、胃がん症例により成長が期待されます。したがって、この地域は、市場参加者が予測期間中に成長するための巨大な可能性を持っています。

ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場の市場機会

ヘリコバクターピロリ（H. pylori）感染症は、様々な団体や機関が世界各地で開催する会議やイベントを通じて、人々に感染症に対する認識を高め、適切なスクリーニング、感染の早期診断、そして感染症を根絶させるための有効な最先端治療の概要を説明しています。これらの学会・イベントの参加者は、これらの学びを活かして、かかりつけの診療所やヘルスケア施設にピロリ菌検査機器を導入するための体制を整備しています。例えば、2019年2月、アブダビでMENA会議による会議「Helicobacter pylori Update Conference」が開催されました。この会議では、世界レベルの科学・臨床研究、公衆衛生、業界の専門家に会い、話を聞き、交流する機会が提供されました。

消化性潰瘍や胃炎などのピロリ菌感染に対する認識が高まり、検査診断キットが便利かつ迅速に患者の自宅に届けられるようになり、ヘリコバクターピロリ（H. pylori）非侵襲的検査市場にも成長の機会がもたらされています。多くの臨床医が、ポイントオブケア（POC）検査はリアルタイムで結果が得られるため、生命を脅かす事態を早期に発見するための必要条件であると認識しています。中低所得国では、家庭内や医院・病院でのPOC診断・モニタリング機器の普及が見込まれています。また、家庭用検査キットも各社から発売されています。例えば、Labsystems Diagnostics社は、家庭でヘリコバクターピロリIgG抗体を検出するイムノクロマト検査キット「Biocard Helicobacter pylori IgG」を発売しています。このように、世界中でPOC検査法の使用の高まりとともに、ピロリ菌の診断のために個人の間で意識を広めるための様々なイニシアチブは、今後数年間でヘリコバクターピロリ（H. pylori）非侵襲的検査市場のための有利な成長機会を創出すると思われます。

世界保健機関（WHO）、Globocan、世界銀行データ、国民保健サービス（NHS）、PubMed Central、国立生物工学情報センター（NCBI）は、世界のヘリコバクターピロリ（H. pylori）非侵襲的検査市場のレポートを作成中に参照したいくつかの第二の情報源です。

目次

第1章 イントロダクション

  • 調査対象範囲
  • インサイトパートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • ヘリコバクターピロリ（H. pylori）非侵襲的検査の世界市場-検査タイプ別
    • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場- 検査方法別
    • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場-エンドユーザー別
    • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場-地域別

第2章 重要なポイント

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場- 市場情勢

  • PEST分析
    • 北米PEST分析
    • 欧州PEST分析
    • アジア太平洋地域PEST分析
    • 中東・アフリカPEST分析
    • 中南米PEST分析
  • 専門家の見解

第5章 ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場- 主要な産業力学

  • 主な市場促進要因
    • ピロリ菌感染症の有病率の増加
    • 非侵襲的検査の新製品発売とFDA承認
    • ピロリ菌の診断に関する個人の意識の普及
    • 製薬会社別投資の増加
  • 主な市場抑制要因
    • 低い診断率
  • 主な市場機会
    • 研究のための学会やイベントの増加
    • 人工知能のイントロダクション
  • 今後の動向
    • 家庭用POCデバイスの利用拡大
    • 耐性診断
  • インパクト分析

第6章 ヘリコバクターピロリ（H.pylori）非侵襲的検査市場-世界分析

  • ヘリコバクターピロリ（H. pylori）非侵襲的検査の世界市場収益と予測・分析
  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場：地域別予測・分析
  • 主要プレイヤーの市場ポジショニング
  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場-地域別市場ポテンシャル分析
  • 比較企業分析
  • 成長戦略分析
  • 主要プレイヤーの業績
    • アボット社
    • DiaSorin S.p.A.

第7章 ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場分析-検査タイプ別

  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場：検査タイプ別2022年・2028年（%）
  • 血清学的検査
  • 便中抗原検査
  • 尿素ブレステスト

第8章 ヘリコバクターピロリ（H. pylori）非侵襲的検査の世界市場分析-検査方法別

  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場：検査方法別2022年・2028年（%）
  • ラボラトリーベース検査
  • ポイントオブケア検査

第9章 ヘリコバクターピロリ（H. pylori）非侵襲的検査の世界市場分析-エンドユーザー別

  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査の世界市場：エンドユーザー別2018 &2028（%）
  • 病院
  • 診療所
  • 診断ラボラトリー

第10章 ヘリコバクターピロリ（H. pylori）非侵襲的検査市場の収益と2028年までの予測- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
    • アジア太平洋地域
      • 中国
      • 日本
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域
  • 中東・アフリカ地域
    • UAE
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ地域

第11章 H.ピロリ非侵襲的検査市場へのCOVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ地域
  • 中南米

第12章 ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場-業界情勢

  • ヘリコバクターピロリ（H.ピロリ）非侵襲的検査市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • DiaSorin S.p.A.
  • Meridian Bioscience, Inc.
  • QuidelOrtho Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • CerTest Biotec
  • Sekisui Diagnostics
  • Coris BioConcept
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • Bio-Rad Laboratories, Inc.

第14章 付録

  • インサイト・パートナーズについて
  • 用語解説
図表

List Of Tables

  • Table 1. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 21. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 35. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 38. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 41. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 44. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 47. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 50. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 53. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 56. Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
  • Table 57. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 59. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
  • Table 60. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 61. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 62. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
  • Table 63. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 64. South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 65. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
  • Table 66. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 67. Rest of Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 68. Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
  • Table 69. Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 70. South and Central America Helicobacter Pylori : Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 71. South and Central America Helicobacter Pylori :Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (USD Million)
  • Table 72. South and Central America Helicobacter Pylori: Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
  • Table 74. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (USD Million)
  • Table 75. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 77. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (USD Million)
  • Table 78. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 79. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 80. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (USD Million)
  • Table 81. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  • Table 82. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
  • Table 83. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation
  • Figure 2. Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Region
  • Figure 3. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview
  • Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in Helicobacter Pylori (H. pylori) Non-invasive Testing Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Geography (US$ Million)
  • Figure 7. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market- Revenue Forecast and Analysis - 2020 - 2028
  • Figure 17. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - By Geography Forecast and Analysis - 2022 - 2028
  • Figure 18. Market Positioning of Key Players in Helicobacter pylori (H. pylori) Non-Invasive Testing Market
  • Figure 19. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Market Potential Analysis, By Region
  • Figure 20. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Comparative Company Analysis
  • Figure 21. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Growth Strategy Analysis
  • Figure 22. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)
  • Figure 23. Global Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. Global Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Global Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)
  • Figure 27. Global Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Global Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)
  • Figure 30. Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Global Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Global Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 33. North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 34. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  • Figure 36. US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 40. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  • Figure 42. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Overview, by Country (2022)
  • Figure 49. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 50. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
  • Figure 51. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 52. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 53. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 54. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 56. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue Overview, by Country, 2022 (US$ Million)
  • Figure 58. Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  • Figure 60. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. South and Central America Helicobacter Pylori (H. pylori) Noninvasive Testing Market Revenue Overview, by Country, 2022 (US$ Mn)
  • Figure 65. South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 66. South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 67. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 68. Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 69. RoSCAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 70. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 71. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 72. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  • Figure 73. Impact of COVID-19 Pandemic on the Middle East and Africa Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 75. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
目次
Product Code: TIPRE00005185

The Helicobacter Pylori (H. pylori) Non-Invasive Testing market is expected to grow from US$ 596.82 million in 2021 to US$ 800.04 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2022 to 2028.

Increasing prevalence of H. pylori bacterial infection, spreading awareness among individuals regarding the diagnosis of H. pylori, and new product launches & FDA approvals fuel the overall market growth.

The prevalence of the gastric disease is significantly higher in the geriatric population as aging increases the risk of H. pylori infection. Increased age leads to thinning of the stomach lining, thus allowing the bacteria to pass through the protective lining that contributes to the growing prevalence of infection among older people. According to World Health Organization (WHO), the population percentage aged 60 years and above is expected to be 13.7% globally and 20.3% in the south-east Asia region by 2030. With the subsequent increase in the geriatric population, the demand for primary care services, including screening, assessment, and management of clinical and functional comorbidities, is increasing. These statistics determine an increase in the need for diagnostics in various regions across the globe, which is boosting the growth of the Helicobacter pylori (H. pylori) non-invasive testing market during the forecast period.

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Segmental Overview

Based on the test type, the Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breath. The urea breath segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period owing to rising product development trends among prominent players. Based on test method, the Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory-based and point-of-care. In 2021, the laboratory-based segment held a larger market share, and it is expected to register a higher CAGR from 2022 to 2028 due to the healthcare professionals operating with testing procedures, making the diagnostics procedures more accurate. Based on end users, the Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. In 2021, the diagnostic laboratories segment held the largest share of the market, and it is expected to register the highest CAGR from 2022 to 2028, owing to the increasing number of tests carried out in labs and rising competition in the industry demands competitive prices and the best possible services.

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Geographical Overview

North America holds the largest share of the global Helicobacter Pylori (H. pylori) non-invasive testing market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the growing prevalence of stomach cancer, duodenal ulcers, and gastric ulcers and the development of health care facilities.

Asia Pacific is likely to register the highest CAGR in the global H. pylori non-invasive testing market during the forecast period. The market in the region is expected to grow significantly in various countries, including China, India, and Japan, in the coming years. The Asia Pacific Helicobacter Pylori (H. pylori) non-invasive testing market is expected to grow due to the rising geriatric population, high prevalence of H. pylori, and gastric cancer cases. Therefore, the region holds huge potential for the market players to grow during the forecast period.

Market Opportunities of Helicobacter Pylori (H. pylori) Non-Invasive Testing Market

The different conferences and events held globally by various organizations and institutes make people aware of H. pylori infections and give an overview of appropriate vital screening, early diagnosis of infection, and its effective cutting-edge treatment in successfully eradicating the infection. Participants in these conferences/events utilize these learnings to develop a framework for introducing H. pylori testing devices for their family practice and healthcare facilities. For instance, in February 2019, a conference "Helicobacter pylori Update Conference" was held in Abu Dhabi by the MENA conference. This conference offered the opportunity to meet, listen to and interact with world-class scientific and clinical research, public health, and industry experts.

The increasing awareness of H. pylori infections such as peptic ulcers and gastritis is bringing the test diagnostics kits conveniently and quickly to the patient at home, which is also providing growth opportunities to the Helicobacter Pylori (H. pylori) non-invasive testing market. Many clinicians recognize point-of-care (POC) testing as a requirement for the early detection of life-threatening situations because the results can be made available in real-time. In low- and middle-income countries, POC diagnostic and monitoring devices are anticipated to become universal in-home setups and at doctor's offices or hospitals. Also, various companies are offering test kits for home use; for instance, Labsystems Diagnostics offers Biocard Helicobacter pylori IgG an immunochromatographic test for the detection of H. pylori IgG antibodies at home. Thus, various initiative to spread awareness among individuals for diagnosis of H. pylori along with the rising use of POC testing methods across the world is likely to create lucrative growth opportunities for the Helicobacter Pylori (H. pylori) non-invasive testing market in the coming years.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), PubMed Central, and National Center for Biotechnology Information (NCBI) are a few secondary sources referred to while preparing the report on the global Helicobacter Pylori (H. pylori) non-invasive testing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the H. pylori non-invasive testing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global H. pylori non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Type
    • 1.3.2 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
    • 1.3.3 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
    • 1.3.4 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing prevalence of H. pylori bacterial infection
    • 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
    • 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
    • 5.1.4 Rise in Investments by Pharmaceutical Companies
  • 5.2 Key Market Restraints
    • 5.2.1 Low Diagnosis Rate
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Number of Conferences and Events for Research
    • 5.3.2 Introduction of Artificial Intelligence
  • 5.4 Future Trends
    • 5.4.1 Increasing Use of Home-Based POC Devices
    • 5.4.2 Diagnosis for Resistance
  • 5.5 Impact Analysis

6. Helicobacter pylori (H. pylori) Non-Invasive Testing Market- Global Analysis

  • 6.1 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis
  • 6.2 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players
  • 6.4 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Market Potential Analysis, By Region
  • 6.5 Comparative Company Analysis
  • 6.6 Growth Strategy Analysis
  • 6.7 Performance of Key Players
    • 6.7.1 Abbott
    • 6.7.2 DiaSorin S.p.A.

7. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis- by Test Type

  • 7.1 Overview
  • 7.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
  • 7.3 Serology Test
    • 7.3.1 Overview
    • 7.3.2 Global Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.4 Stool Antigen Test
    • 7.4.1 Overview
    • 7.4.2 Global Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.5 Urea Breath Test
    • 7.5.1 Overview
    • 7.5.2 Global Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis- by Test Method

  • 8.1 Overview
  • 8.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
  • 8.3 Laboratory Based Tests
    • 8.3.1 Overview
    • 8.3.2 Global Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • 8.4 Point Of Care Tests
    • 8.4.1 Overview
    • 8.4.2 Global Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market Analysis- by End User

  • 9.1 Overview
  • 9.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By End User 2018 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 Global Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.5 Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
    • 10.1.1 Overview
    • 10.1.2 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
    • 10.1.4 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
    • 10.1.5 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
    • 10.1.6 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
      • 10.1.6.1 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
  • 10.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.4 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.4 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.5 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.4 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.5 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.4 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.5 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.5 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.4 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.3 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.1.4 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.1.5 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.3.6.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.3.6.3 India Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.3 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.3.5 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.3.6.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.3.6.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  • 10.4 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 10.4.4 Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
    • 10.4.5 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 10.4.6.1.4 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
        • 10.4.6.1.5 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.4.6.2 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
        • 10.4.6.2.5 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.4.6.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 10.4.6.3.4 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
        • 10.4.6.3.5 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.4.6.4 Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of the Middle East and Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
  • 10.5 South And Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028
    • 10.5.1 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 10.5.2 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
    • 10.5.3 South and Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
    • 10.5.4 South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
    • 10.5.5 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)
      • 10.5.5.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.1.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.1.2 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
        • 10.5.5.1.3 Argentina Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
        • 10.5.5.1.4 Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
      • 10.5.5.2 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.2.1 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.2.2 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)
        • 10.5.5.2.3 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)
        • 10.5.5.2.4 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)
      • 10.5.5.3 Rest of South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.3.1 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
        • 10.5.5.3.2 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
        • 10.5.5.3.3 RoSCAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
        • 10.5.5.3.4 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on H. pylori Non-Invasive Testing Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profile

  • 13.1 DiaSorin S.p.A.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Meridian Bioscience, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 QuidelOrtho Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Abbott Laboratories
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 CerTest Biotec
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Sekisui Diagnostics
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Coris BioConcept
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Bio-Rad Laboratories, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms